Immunotech Laboratories, Inc.
IMMB · OTC
12/31/2016 | 12/31/2013 | 12/31/2009 | 12/31/2005 | |
|---|---|---|---|---|
| Market Cap | $57 | $44 | $0 | $0 |
| - Cash | $14 | $1 | $5 | $47 |
| + Debt | $2,418 | $1,646 | $1,196 | $0 |
| Enterprise Value | $2,461 | $1,689 | $1,191 | -$47 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$306 | -$547 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$454 | -$589 | -$945 | -$2,027 |
| % Margin | – | – | – | – |
| Net Income | -$493 | -$626 | -$978 | -$33,595 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.001 | 0 | -802 |
| % Growth | 35.7% | – | 100% | – |
| Operating Cash Flow | -$31 | -$312 | – | -$283 |
| Capital Expenditures | -$0 | -$11 | – | $0 |
| Free Cash Flow | -$31 | -$323 | – | -$283 |